NCT06898450
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06898450
Title A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients with Advanced Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nimbus Wadjet, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | IRL | FRA | ESP | AUS


No variant requirements are available.